Evidence mapPaperPMID 38381379Full record

ReviewIrish journal of medical science2024

Vitamin B

Mazhar Salim Al Zoubi, Rasha Al Kreasha, Sarah Aqel, Ahmad Saeed, Ahmad R Al-Qudimat, Raed M Al-Zoubi

Abstract readReview
In one paragraph

Review in Irish journal of medical science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Metabolic dysfunction and the use of adjunct medications in type 1 diabetes.Current opinion in endocrinology, diabetes, and obesity · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mazhar Salim Al ZoubiDepartment of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid, 211-63, Jordan.ORCID http://orcid.org/0000-0003-0248-4777
Rasha Al KreashaDepartment of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid, 211-63, Jordan.
Sarah AqelDepartment of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid, 211-63, Jordan.
Ahmad SaeedDepartment of Basic Medical Sciences, Faculty of Medicine, Yarmouk University, Irbid, 211-63, Jordan.
Ahmad R Al-QudimatSurgical Research Section, Department of Surgery, Hamad Medical Corporation, 3050, Doha, Qatar.ORCID http://orcid.org/0000-0003-1161-7244
Raed M Al-ZoubiSurgical Research Section, Department of Surgery, Hamad Medical Corporation, 3050, Doha, Qatar. ralzoubi@hamad.qa.ORCID http://orcid.org/0000-0002-0548-429X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metformin is the most prescribed oral hypoglycemic drug and is considered by many health practitioners as the first-line treatment for non-insulin-dependent diabetes mellitus (T2DM). It is used either as a monotherapy or adjuvant to other anti-hyperglycemic agents. Most of its side effects are usually mild and self-limiting. However, several studies have shown an association between the use of metformin and low vitamin B

Indexed as

Diabetes Mellitus, Type 2Hypoglycemic AgentsMetforminVitamin B 12 DeficiencyFemaleHumansMaleRisk FactorsVitamin B 12Hypoglycemic AgentsMetforminVitamin B 12B12 deficiencyDiabetes mellitusMetforminT2DM

Identifiers

PMID38381379
PMCPMC11294377

What Socratic holds

Texttitle and abstract
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.